|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$102,235.77 |
3.21% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$99,241.54 |
3.12% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$94,717.54 |
2.98% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$87,892.29 |
2.76% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$85,267.98 |
2.68% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$84,180.40 |
2.65% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$81,807.72 |
2.57% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$79,903.36 |
2.51% |
| Waters Corporation |
WAT |
941848103 |
184 |
$79,506.40 |
2.50% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$79,132.32 |
2.49% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$78,144.32 |
2.46% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$77,544.00 |
2.44% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$76,892.62 |
2.42% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$76,140.06 |
2.39% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$72,633.80 |
2.28% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$72,155.98 |
2.27% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$70,778.93 |
2.23% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$70,289.64 |
2.21% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$70,335.45 |
2.21% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$70,020.29 |
2.20% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$68,572.00 |
2.16% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$65,397.23 |
2.06% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$64,206.22 |
2.02% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$62,598.60 |
1.97% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$62,144.68 |
1.95% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$60,599.32 |
1.91% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$60,526.80 |
1.90% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$59,870.16 |
1.88% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$58,878.76 |
1.85% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$58,401.22 |
1.84% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$58,343.61 |
1.83% |
| Steris Plc |
STE |
G8473T100 |
265 |
$58,029.70 |
1.82% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$57,130.88 |
1.80% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$55,593.20 |
1.75% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$54,666.18 |
1.72% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$52,436.59 |
1.65% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$51,285.09 |
1.61% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$49,708.48 |
1.56% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$49,172.40 |
1.55% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$48,398.49 |
1.52% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$48,194.90 |
1.52% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$47,742.80 |
1.50% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$46,428.86 |
1.46% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$45,991.28 |
1.45% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,532.37 |
1.40% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$43,618.63 |
1.37% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$42,615.74 |
1.34% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$41,867.20 |
1.32% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$41,943.00 |
1.32% |
| US Dollar |
$USD |
|
12,767 |
$12,766.75 |
0.40% |
| Australian Dollar |
$AUD |
|
601 |
$418.10 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|